Maintenance fees coming due

Array Biopharma Inc.

32 maintenance fees come due in the 12 months from Nov 14, 2026, the next on Jan 16, 2027. Unpaid by Jul 16, 2027, that one lapses early.

A maintenance fee does not end a patent on its due date. It falls due at 3.5, 7.5 and 11.5 years from grant, and the patent lapses only if the fee is still unpaid at the end of the six month grace period that follows.

Patent	Title	Holder	Status	Fee due	Lapses if unpaid	Expires	Confidence
US 10,351,575	Bicyclic Urea, Thiourea, Guanidine and Cyanoguanidine Compounds Useful for the Treatment of Pain Array Biopharma Inc. In force Fee due Jan 16, 2027 Lapses if unpaid Jul 16, 2027 Term ends Jul 18, 2035 · High confidence	Array Biopharma Inc.	In force	Jan 16, 2027	Jul 16, 2027	Term ends Jul 18, 2035	High confidence
US 10,398,683	Preparation of and Formulation Comprising a Mek Inhibitor Array Biopharma Inc. In force Fee due Mar 3, 2027 Lapses if unpaid Sep 3, 2027 Term ends Oct 18, 2033 · High confidence	Array Biopharma Inc.	In force	Mar 3, 2027	Sep 3, 2027	Term ends Oct 18, 2033	High confidence
US 9,127,013	METHOD OF TREATMENT USING SUBSTITUTED PYRAZOLO[1,5-a] PYRIMIDINE COMPOUNDS Array Biopharma, Inc. In force Fee due Mar 8, 2027 Lapses if unpaid Sep 8, 2027 Term ends Oct 21, 2029 · High confidence	Array Biopharma, Inc.	In force	Mar 8, 2027	Sep 8, 2027	Term ends Oct 21, 2029	High confidence
US 9,133,187	Serine/Threonine Kinase Inhibitors Array Biopharma, Inc. In force Fee due Mar 15, 2027 Lapses if unpaid Sep 15, 2027 Term ends Feb 28, 2032 · High confidence	Array Biopharma, Inc.	In force	Mar 15, 2027	Sep 15, 2027	Term ends Feb 28, 2032	High confidence
US 11,780,835	PYRAZOLO[3,4-b]PYRIDINE COMPOUNDS AS INHIBITORS OF TAM AND MET KINASES Array BioPharma Inc. In force Fee due Apr 10, 2027 Lapses if unpaid Oct 12, 2027 Term ends Aug 29, 2039 · High confidence	Array BioPharma Inc.	In force	Apr 10, 2027	Oct 12, 2027	Term ends Aug 29, 2039	High confidence
US 10,441,581	Substituted Pyrazolo[1,5-a]pyridine Compounds as Ret Kinase Inhibitors Array Biopharma Inc. In force Fee due Apr 15, 2027 Lapses if unpaid Oct 15, 2027 Term ends Oct 10, 2037 · High confidence	Array Biopharma Inc.	In force	Apr 15, 2027	Oct 15, 2027	Term ends Oct 10, 2037	High confidence
US 9,168,254	Polymorphs of ARRY-380, a Selective Her 2 Inhibitor and Pharmaceutical Compositions Containing Them Array Biopharma, Inc. In force Fee due Apr 27, 2027 Lapses if unpaid Oct 27, 2027 Term ends Oct 12, 2032 · High confidence	Array Biopharma, Inc.	In force	Apr 27, 2027	Oct 27, 2027	Term ends Oct 12, 2032	High confidence
US 10,485,788	Pharmaceutical Combinations Array Biopharma Inc. In force Fee due May 26, 2027 Lapses if unpaid Nov 26, 2027 Term ends Jun 2, 2037 · High confidence	Array Biopharma Inc.	In force	May 26, 2027	Nov 26, 2027	Term ends Jun 2, 2037	High confidence
US 11,834,453	SUBSTITUTED PYRIMIDO[5,4-d]PYRIMIDINES AS HER2 INHIBITORS Array BioPharma Inc. In force Fee due Jun 5, 2027 Lapses if unpaid Dec 6, 2027 Term ends Jun 29, 2041 · High confidence	Array BioPharma Inc.	In force	Jun 5, 2027	Dec 6, 2027	Term ends Jun 29, 2041	High confidence
US 11,851,434	Substituted Pyrazolo[1,5-a]pyrazine Compounds as Ret Kinase Inhibitors Array Biopharma Inc. In force Fee due Jun 26, 2027 Lapses if unpaid Dec 27, 2027 Term ends Jan 18, 2038 · High confidence	Array Biopharma Inc.	In force	Jun 26, 2027	Dec 27, 2027	Term ends Jan 18, 2038	High confidence
22 more maintenance fees coming due in the 12 months from Nov 14, 2026 · Pro

10 of 32 patents shown. Soonest fee due date first, then patent number.

Pro members see every patent with a maintenance fee coming due: number, title, status, the due date, and the date it lapses if the fee goes unpaid through the grace period.

Upgrade to Pro

Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.